Establishment of control materials for human BCR-ABL fusion gene

QU Shou-fang<sup>1</sup>, YU Ting<sup>1</sup>, ZHANG Juan-li<sup>2</sup>, HU Xiao-xu<sup>3</sup>, GUO Li-ping<sup>3</sup>, ZHAO Jin-yin<sup>4</sup>, GAO Shang-xian<sup>1</sup>, HUANG Jie<sup>1</sup>

doi:10.16155/j.0254-1793.2016.09.17

Chinese Journal of Pharmaceutical Analysis >

2016 , Vol. 36 >Issue 9: 1629 - 1633

DOI: https://doi.org/10.16155/j.0254-1793.2016.09.17

Establishment of control materials for human BCR-ABL fusion gene

Expand

1. National Institutes for Food and Drug Control, Beijing 100050, China;
2. Henan Medical Equipment Inspection Institute, Zhengzhou 450003, China;
3. Beijing Institute of Genomics Chinese Academy of Sciences, Beijing 100101, China;
4. Dalian GenTalker Clinical Laboratory, Dalian 116635, China

Online published: 2024-05-31

Fold

Cite this article

QU Shou-fang¹, YU Ting¹, ZHANG Juan-li², HU Xiao-xu³, GUO Li-ping³, ZHAO Jin-yin⁴, GAO Shang-xian¹, HUANG Jie¹ . Establishment of control materials for human BCR-ABL fusion gene[J]. Chinese Journal of Pharmaceutical Analysis, 2016 , 36(9) : 1629 -1633 . DOI: 10.16155/j.0254-1793.2016.09.17

Options

Abstract

Outlines

模态框（Modal）标题

Cite this article